Status:
COMPLETED
The Efficacy Tretinoin Cream in the Treatment of Axillary Hyperpigmentation Associated With Acanthosis Nigricans
Lead Sponsor:
Srinakharinwirot University
Conditions:
Acanthosis Nigricans
Hyperpigmentation
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
The goal of this randomized intra-individual design with a split-side axillary approach is to comparing the efficacy of 0.025% tretinoin cream against a cream-based formulation in the treatment of axi...
Detailed Description
This study employed a randomized intra-individual design with a split-side axillary approach, comparing the efficacy of 0.025% tretinoin cream against a cream-based formulation. Participants were rand...
Eligibility Criteria
Inclusion
- The participants aged over 18 years with BMI more than 25 kg/m2, axillary hyperpigmentation associated with acanthosis nigricans
Exclusion
- Vulnerable skin diseases
- Infectious skin diseases
- Other recent diseases involving the axillary
- Other serious medical disorders e.g. liver disease
- Any patients having received other therapies for up to 4 weeks prior to enrollment
- Photosensitive skin
- Immunocompromised host
- Pregnancy and lactation
- Receiving oral retinoids
- Axillary tattoo
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06213987
Start Date
February 1 2024
End Date
June 1 2024
Last Update
August 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arucha Treesirichod
Ongkharak, Changwat Nakhon Nayok, Thailand, 26120